Viewing StudyNCT03585686



Ignite Creation Date: 2024-05-06 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 12:49 PM
Study NCT ID: NCT03585686
Status: RECRUITING
Last Update Posted: 2023-03-16
First Post: 2018-07-06

Brief Title: A Combination of Vemurafenib Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutation
Sponsor: Federal Research Institute of Pediatric Hematology Oncology and Immunology
Organization: Federal Research Institute of Pediatric Hematology Oncology and Immunology

Conditions & Keywords Data

Conditions:
Name
Langerhans Cell Histiocytosis
Keywords:
Name View
BRAF View
LCH View
Langerhans View
histiocytosis View
vemurafenib View